Open original FDA record ↗Recall record
- FDA identifier
- Z-1120-2017
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA record creation date
- Jan 31, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Negative bias results with the IMMULITE /IMMULITE 1000 Third Generation PSA (prostate-specific antigen) kit was confirmed for two lots (D0119 and D0120). The investigation by Siemens has confirmed that patient samples exhibit an average negative bias of approximately -22% with a range of -16% to -27% for samples recovering from 0.08 to 16.2 ng/mL.
Source facts
- Action
- Siemens issued an Urgent Medical Device Recall Notice letter dated December 21, 2016, to their U.S.A customers via Fed Ex and an Urgent Field Safety Notice letter dated December 2016, to customers outside the US (OUS). The notices instruct customers to discontinue use of and discard the affected kit lots listed in Table 1 of the customer communication. Customers are requested to review the UMDR and or the UFSN with their Medical Director. Customers are requested to complete and return the Effectiveness Check questionnaire attached to the Urgent Medical Device Recall letter within 30 days. U.S.A customers are advised to fax the Effectiveness Check questionnaire to (312) 275-7795. Field service personnel will be sent an SKB (Service Knowledge Base) describing the issue and instructing them how to deal with customer questions. Customers with questions should contact their local Siemens technical support representative.
- Initiated
- 2016-12-21
- Root cause
- Nonconforming Material/Component
- Terminated
- 2018-06-07
- Distribution
- Worldwide Distribution - US Nationwide and the countries of Denmark, Brazil, Croatia and Germany
- Recall number
- Z-1120-2017
- Recall status
- Terminated
- CDRH record ID
- 152223
- FDA record created
- 2017-01-31
- Recall event number
- 76124